Literature DB >> 9489740

Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.

Y Du1, K R Bales, R C Dodel, X Liu, M A Glinn, J W Horn, S P Little, S M Paul.   

Abstract

Beta-amyloid peptides (A beta) are deposited in an aggregated fibrillar form in both diffuse and senile plaques in the brains of patients with Alzheimer's disease. The neurotoxicity of A beta in cultured neurons is dependent on its aggregation state, but the factors contributing to aggregation and fibril formation are poorly understood. In the present study, we investigated whether alpha2-macroglobulin (alpha2M), a protein present in neuritic plaques and elevated in Alzheimer's disease brain, is a potential regulatory factor for A beta fibril formation. Previous studies in our laboratory have shown that alpha2M is an A beta binding protein. We now report that, in contrast to another plaque-associated protein, alpha1-antichymotrypsin, alpha2M coincubated with A beta significantly reduces aggregation and fibril formation in vitro. Additionally, cultured fetal rat cortical neurons are less vulnerable to the toxic actions of aged A beta following pretreatment with alpha2M. We postulate that alpha2M is able to maintain A beta in a soluble state, preventing fibril formation and associated neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489740     DOI: 10.1046/j.1471-4159.1998.70031182.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 2.  Low-density lipoprotein receptor family: endocytosis and signal transduction.

Authors:  Y Li; J Cam; G Bu
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

3.  Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.

Authors:  Xing Wei; Yvonne Roettger; Bailin Tan; Yongzheng He; Richard Dodel; Harald Hampel; Gang Wei; Jillian Haney; Huiying Gu; Brian H Johnstone; Junyi Liu; Martin R Farlow; Yansheng Du
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

Review 4.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

5.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

Review 6.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

7.  Expression of Panza, an alpha2-macroglobulin, in a restricted dorsal domain of the primitive gut in Xenopus laevis.

Authors:  Liliam Pineda-Salgado; Eileen J Craig; Rebecca B Blank; Daniel S Kessler
Journal:  Gene Expr Patterns       Date:  2005-11-07       Impact factor: 1.224

8.  Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer's Patients.

Authors:  Mahdi Zamani; Masomeh Mohammadi; Hamid Zamani; Alireza Tavasoli
Journal:  Mol Neurobiol       Date:  2015-08-21       Impact factor: 5.590

9.  Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein.

Authors:  Celina V Zerbinatti; David F Wozniak; John Cirrito; Judy A Cam; Hiroshi Osaka; Kelly R Bales; Min Zhuo; Steven M Paul; David M Holtzman; Guojun Bu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

10.  Direct Transcriptional Effects of Apolipoprotein E.

Authors:  Veena Theendakara; Clare A Peters-Libeu; Patricia Spilman; Karen S Poksay; Dale E Bredesen; Rammohan V Rao
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.